Orionis Biosciences SRL
36.3 FTEOrionis Biosciences reported revenue of €11.6m for the 2025 financial year (annual accounts filed with the NBB on 14 Jul 2026), with 36.3 full-time equivalents.
By total assets for 2025, Orionis Biosciences ranks among the 200 largest of the 994 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Orionis Biosciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +40 % Total assets +3 % Headcount (avg FTE) +5 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Orionis Biosciences's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €11.6m | ||||
| Net result | 585,117 € | ||||
| Equity | €4.92m | ||||
| Cash | 717,707 € | ||||
| EBITDA | €1.29m | ||||
| Total assets | €6.88m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
Orionis Biosciences's financial analysis
- Solvency71.6%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Orionis Biosciences
Orionis Biosciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0635.962.088
- VAT number
- BE0635962088
- Peppol
- Registered · 0208:0635962088 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Sep 2015
- Registered office
- 9052 Ghent
- Size
- Small · 36.3 FTE
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Orionis Biosciences (SRL) has been based in Ghent since 2015, active in: research and experimental development on biotechnology. For 2025, it reports revenue of €11.6m, a net profit of 585,117 € and equity of €4.92m. With 36.3 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 71.6%, above the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Orionis Biosciences
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- BioKuris Research and experimental development on natural sciences and engineering Herstal · balance sheet €5.85m
- Cryoport Belgium Research and experimental development on natural sciences and engineering Villers-le-Bouillet · balance sheet €16.2m
- Hebrimo Solar 21 Research and experimental development on natural sciences and engineering Herentals · balance sheet €4.71m
- CM4Cure Research and experimental development on natural sciences and engineering Liège · balance sheet €4.57m
- Inari Agriculture, NV Research and experimental development on natural sciences and engineering Ghent · balance sheet €12.1m
- HepaVue Dx Research and experimental development on natural sciences and engineering Waterloo · balance sheet €3.71m
- Envitec Measurements and Analytics SA Research and experimental development on natural sciences and engineering Gembloux · balance sheet €3.64m
Frequently asked questions about Orionis Biosciences
What is the revenue of Orionis Biosciences?
According to the 2025 annual accounts filed with the NBB, the revenue of Orionis Biosciences amounts to 11,559,383 €.
What is the VAT number of Orionis Biosciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0635962088 for Orionis Biosciences, if the company is VAT-registered. Its company number (CBE) is 0635.962.088.
Where is the registered office of Orionis Biosciences?
According to the CBE register, the registered office of Orionis Biosciences is in 9052 Ghent.
What is the equity of Orionis Biosciences?
At the close of the 2025 financial year, the equity of Orionis Biosciences amounts to 4,924,048 €, a solvency of 71.6% of total assets.
How many people work at Orionis Biosciences?
36.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Orionis Biosciences?
The register lists 6 active mandates at Orionis Biosciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Orionis Biosciences within its sector?
By total assets for 2025, Orionis Biosciences ranks among the 200 largest of the 994 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Orionis Biosciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →